|

TTX-MC138 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • QuantumLeap Healthcare Collaborative1

Indications

  • Neoplasm, Residual1
  • Adenocarcinoma of Colon1
  • PR-positive Breast Cancer1
  • Progesterone Receptor-positive Breast Cancer1
  • Estrogen Receptor Positive Tumor1

Birmingham, Alabama1 trial

PRE-ISPY Phase I/II Oncology Platform Program

The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.